Utilization of sacubitril–valsartan for Right Ventricular Failure in a Patient With Arrhythmogenic Right Ventricular Cardiomyopathy
- 15 June 2022
- journal article
- research article
- Published by Taylor & Francis in Future Cardiology
- Vol. 18 (7) , 547-552
Abstract
Arrhythmogenic right ventricular (RV) cardiomyopathy is an autosomal dominant inherited cardiomyopathy that is characterized by an increased risk of ventricular arrhythmias, sudden cardiac death an... Plain language summary The authors present the case of a 36-year-old woman who was found to have arrhythmogenic right ventricular cardiomyopathy, a rare inherited cardiomyopathy. This condition is ...Keywords
This publication has 17 references indexed in Scilit:
- Impact of Sacubitril/Valsartan on the Long-Term Incidence of Ventricular Arrhythmias in Chronic Heart Failure PatientsJournal of Clinical Medicine, 2019
- Heart failure in patients with arrhythmogenic right ventricular cardiomyopathy: Genetic characteristicsInternational Journal of Cardiology, 2019
- Clinical Diagnosis, Imaging, and Genetics of Arrhythmogenic Right Ventricular Cardiomyopathy/DysplasiaJACC, 2018
- Survival After Heart Transplantation in Patients With Arrhythmogenic Right Ventricular CardiomyopathyJournal of Cardiac Failure, 2017
- Sacubitril/Valsartan (LCZ696) in Heart Failure2016
- Combined Angiotensin Receptor Antagonism and Neprilysin InhibitionCirculation, 2016
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart FailureNew England Journal of Medicine, 2014
- Arrhythmogenic Right Ventricular DysplasiaCurrent Problems in Cardiology, 2013
- Quantitative Evaluation of Drug or Device Effects on Ventricular Remodeling as Predictors of Therapeutic Effects on Mortality in Patients With Heart Failure and Reduced Ejection FractionJACC, 2010
- Inhibition of testosterone biosynthesis by ethanol: Multiple sites and mechanisms in dispersed leydig cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1987